Katherine E Kurgansky

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Placebo Controlled

Coronavirus Disease

Quality Improvement

Top Venues

Journal of the American Heart Association

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Katherine E Kurgansky, Rachel Parker, Luc Djoussé, David R Gagnon, Jacob Joseph
Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association (2024)
Katherine E Kurgansky, Rachel Parker, Luc Djoussé, David R Gagnon, Jacob Joseph
Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association 13 (14) (2024)
Katherine E Kurgansky, Rachel Parker, Luc Djoussé, David R Gagnon, Jacob Joseph
Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association 13 (14) (2024)
Katherine E Kurgansky, Rachel Parker, Luc Djoussé, David R Gagnon, Jacob Joseph
Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association 13 (14) (2024)
Barbra A Dickerman, Hanna Gerlovin, Arin L Madenci, Katherine E Kurgansky, Brian R Ferolito, Michael J Figueroa Muñiz, David R Gagnon, J Michael Gaziano, Kelly Cho, Juan P Casas, Miguel A Hernán
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans. The New England journal of medicine 386 (2) (2021)